IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Porter, J. D.
Right arrow Articles by Burns, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Porter, J. D.
Right arrow Articles by Burns, L. A.

Investigative Ophthalmology & Visual Science, Vol 29, 163-174, Copyright © 1988 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Extraocular myotoxicity of the retrobulbar anesthetic bupivacaine hydrochloride

JD Porter, DP Edney, EJ McMahon and LA Burns
Department of Anatomy, University of Mississippi Medical Center, Jackson 39216.

Morphopathological changes induced in the extraocular muscles by the local anesthetic agent bupivacaine hydrochloride were studied in the monkey using light and electron microscopy. Retrobulbar anesthetic blocks, using 0.75% bupivacaine hydrochloride, were performed in five adult cynomolgus monkeys. Morphological alterations in extraocular muscle fiber types were examined following survival periods of 3-27 days. Bupivacaine injections produced a mild and very limited myopathic response, with changes largely restricted to the global layer singly- innervated muscle fiber type which is characterized by low mitochondrial content. For survival times beyond 3 days, this fiber type exhibited peripheral migration and swelling of mitochondria and an outside-in pattern of myofibril dissolution. Some affected fibers also exhibited the Ringbinden or ring fiber pathology. Maximal myotoxic response was observed at 14 days after injections, and pathological changes were largely resolved by 27 days. A more limited analysis of the effects of retrobulbar injection of lidocaine revealed similar morphopathological responses, thereby suggesting that these effects are a property common to the entire class of aminoacyl anesthetics. In contrast to previous observations in other skeletal musculature, the extraocular muscles proved to be unexpectedly resistant to local anesthetic treatment as only limited alterations were observed. The observed muscle fiber type specificity was interpreted to result from differences in the relative ability of muscle fiber types to adapt to anesthetic-induced elevations of intracellular free calcium levels.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
W. Irwin, E. Fontaine, L. Agnolucci, D. Penzo, R. Betto, S. Bortolotto, C. Reggiani, G. Salviati, and P. Bernardi
Bupivacaine Myotoxicity Is Mediated by Mitochondria
J. Biol. Chem., March 29, 2002; 277(14): 12221 - 12227.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
T. Gillart, P. Barrau, J. E. Bazin, G. Roche, F. Chiambaretta, and P. Schoeffler
Lidocaine Plus Ropivacaine Versus Lidocaine Plus Bupivacaine for Peribulbar Anesthesia by Single Medial Injection
Anesth. Analg., November 1, 1999; 89(5): 1192 - 1192.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the Association for Research in Vision and Ophthalmology